Sign in
CompletedNo phase

MRI in Randomised Cohorts of Asymptomatic AS

Key facts

Who runs it
University of Leicester
Where
United Kingdom1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
202 people enrolled
Started
28 Jul 2021
Ended
12 May 2026
Type of study
Observational, 2 groups
Treatments tested
  • Surgical/ Transcatheter aortic valve replacement
Record updated
29 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Willing to and able to consent
  • Participant in an RCT randomising patients with asymptomatic severe AS to early AVR vs standard care
  • Severe aortic stenosis, as defined by original trial's inclusion criteria
  • Asymptomatic at the time of randomisation in the RCT
  • Willingness to have 1-2 cardiac MRI scan(s)

Who cannot take part

  • eGFR <30
  • Contra-indication to MRI
  • Severe claustrophobia (precluding MRI)

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Aortic stenosis is narrowing of the aortic valve, and is the commonest type of valve disease requiring surgery. Current guidelines recommend waiting till patients develop symptoms (chest pain, breathlessness and dizzy spells/fainting) before possible open heart surgery to replace the valve is offered. However, studies using detailed 'MRI' scanning of the heart have shown that up to half of the patients already have 'scarring' in the heart by the time symptoms develop. Furthermore, scarring is not fully reversed even after surgery and is associated with worse outcome. This suggests that some patients are being offered treatment too late. Two randomised trials in the UK (EASY AS and EVOLVED) are currently investigating if valve replacement before symptoms will result in better survival. The aim of this study is to compare the effect of early valve replacement versus waiting for symptoms, on the amount of scarring in the heart. The investigators want to know if early treatment leads to less overall scarring at the end, and leads to better quality of life and recovery after surgery. The investigators will invite participants of the EASY AS and EVOLVED trials to have 1-2 MRI heart scans: at recruitment and 2 years after being randomly allocated to early aortic valve replacement vs 'watchful waiting'. The investigators will also assess the impact of the two treatment approaches on quality of life, disability-free survival (using questionnaires) and recovery after surgery. The results from this project will increase understanding of the results of the main trials, and lead to improved selection of patients with aortic stenosis who are likely to benefit from early surgery.

The 2 groups in the trial

  • Early aortic valve replacement

    Asymptomatic severe aortic stenosis patients randomised to early aortic valve replacement

    Treatment: Surgical/ Transcatheter aortic valve replacement

  • Standard care

    Asymptomatic severe aortic stenosis patients randomised to 'watchful waiting' until symptom onset.

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Impact of Early Valve Replacement on Myocardial Scar in Asymptomatic Aortic Stenosis: an Observational MRI Study of Randomised Cohorts
Record updated
29 July 2026